Nancy Denyes is General Counsel at aTYR PHARMA INC (ATYR). They have made 3 open-market trades across 1 company since 2020, most recently 2026-02-04.
1 open-market purchase totalling $9K since 2024, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LIFE | 14,767 | $553K |
| ATYR | 33,124 | $6K |
| Total | $559K |
Shares reported on the most recent Form 4, priced at the 2026-02-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.